F3Logic’s Cardinal Health CAH Stock Holding History

F3Logic’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,198	Closed	-$240K	–	235
2021 Q2	$240K	Buy	+4,198	New	+$245K	0.03%	200

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

F3Logic's CAH Position: Q3 2021 in Review

F3Logic sold out of Cardinal Health (CAH) in Q3 2021, closing a stake of 4,198 shares — an estimated $240K sold.

F3Logic first reported a position in CAH in Q2 2021 and held it in 1 quarter. The position peaked at $240K in Q2 2021. 748 funds tracked by Wall St. Rank hold CAH as of Q3 2021.

F3Logic reported no remaining Cardinal Health position as of Q3 2021 after selling out during the quarter.
F3Logic sold 4,198 Cardinal Health shares in Q3 2021, an estimated $240K.
F3Logic first reported a position in Cardinal Health in Q2 2021 and held it in 1 quarter.
F3Logic's Cardinal Health position peaked at $240K in Q2 2021.
748 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2021.

Based on F3Logic's 13F filing for Q3 2021, filed 12 Nov 2021.